-
2
-
-
0036914221
-
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance
-
Scordo MG, Pengo V, Spina E, Dahl ML, Gusella M, Padrini R (2002) Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance. Clin Pharmacol Ther 72: 702-710.
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 702-710
-
-
Scordo, M.G.1
Pengo, V.2
Spina, E.3
Dahl, M.L.4
Gusella, M.5
Padrini, R.6
-
3
-
-
78650466131
-
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study
-
Zambon CF, Pengo V, Padrini R, Basso D, Schiavon S, Fogar P, Nisi A, Frigo AC, Moz S, Pelloso M, Plebani M (2011) VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Pharmacogenomics 12: 15-25.
-
(2011)
Pharmacogenomics
, vol.12
, pp. 15-25
-
-
Zambon, C.F.1
Pengo, V.2
Padrini, R.3
Basso, D.4
Schiavon, S.5
Fogar, P.6
Nisi, A.7
Frigo, A.C.8
Moz, S.9
Pelloso, M.10
Plebani, M.11
-
4
-
-
35348879239
-
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)
-
Ezekowitz MD, Reilly PA, Nehmiz G et al (2007) Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol 100: 1419-1426.
-
(2007)
Am J Cardiol
, vol.100
, pp. 1419-1426
-
-
Ezekowitz, M.D.1
Reilly, P.A.2
Nehmiz, G.3
-
5
-
-
77950880770
-
Update on antithrombotic therapy. New anticoagulants
-
Eikelboom JW, Weitz JI (2010) Update on antithrombotic therapy. New anticoagulants. Circulation 121: 1523-1532.
-
(2010)
Circulation
, vol.121
, pp. 1523-1532
-
-
Eikelboom, J.W.1
Weitz, J.I.2
-
6
-
-
84866866045
-
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results
-
Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Moia M, Palareti G, Poli D, Testa S, Tiraferri E, Tosetto A, Tripodi A, Siragusa S, Manotti C (2012) Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost 10: 1979-1987.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1979-1987
-
-
Pengo, V.1
Crippa, L.2
Falanga, A.3
Finazzi, G.4
Marongiu, F.5
Moia, M.6
Palareti, G.7
Poli, D.8
Testa, S.9
Tiraferri, E.10
Tosetto, A.11
Tripodi, A.12
Siragusa, S.13
Manotti, C.14
-
7
-
-
80155206426
-
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation
-
Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Palareti G, Poli D, Testa S, Tiraferri E, Tosetto A, Tripodi A, Manotti C (2011) Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. Thromb Haemost 106: 868-876.
-
(2011)
Thromb Haemost
, vol.106
, pp. 868-876
-
-
Pengo, V.1
Crippa, L.2
Falanga, A.3
Finazzi, G.4
Marongiu, F.5
Palareti, G.6
Poli, D.7
Testa, S.8
Tiraferri, E.9
Tosetto, A.10
Tripodi, A.11
Manotti, C.12
-
8
-
-
80053571188
-
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects
-
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124: 1573-1579.
-
(2011)
Circulation
, vol.124
, pp. 1573-1579
-
-
Eerenberg, E.S.1
Kamphuisen, P.W.2
Sijpkens, M.K.3
Meijers, J.C.4
Buller, H.R.5
Levi, M.6
-
9
-
-
84875000370
-
Clinical management of rivaroxaban-treated patients
-
Palareti G, Ageno W, Ferrari A, Filippi A, Imberti D, Pengo V, Rubboli A, Toni D (2013) Clinical management of rivaroxaban-treated patients. Expert Opin Pharmacother 14: 655-667.
-
(2013)
Expert Opin Pharmacother
, vol.14
, pp. 655-667
-
-
Palareti, G.1
Ageno, W.2
Ferrari, A.3
Filippi, A.4
Imberti, D.5
Pengo, V.6
Rubboli, A.7
Toni, D.8
-
10
-
-
80051579089
-
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs
-
Kooiman J, van de Peppel WR, van der Meer FJ, Huisman MV (2011) Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs. J Thromb Haemost 9: 1652-1653.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 1652-1653
-
-
Kooiman, J.1
van de Peppel, W.R.2
van der Meer, F.J.3
Huisman, M.V.4
|